Global Cytomegalovirus Retinitis Market, By Eye Diseases (Glaucoma, Cataract, Ocular Hypertension, Uveitis), Drug Type (Ganciclovir, Valganciclovir, Foscarnet, Cidofovir, Others), Application (Transplantation, Organ transplantation, Congenital CMV infection), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
Cytomegalovirus Retinitis Market Analysis and Size
The vision loss and occurrence of eye disorders are becoming a major health threat which include numerous eye diseases such as glaucoma, cataract, diabetic macular edema, retinal detachment, age-related macular degeneration, ocular hypertension, refractive errors, bulging eyes, and uveitis. Diagnosis through blood or urine test other than other optical tests, which include extraction of a small specimen fluid from the contaminated eye is recommended. This disease is mainly concentrated to patients with pre-existing conditions such as HIV. Hence the total market size of the market will be smaller as CMV retinitis occurs in around 46% of the HIV patients compared to other common diseases.
Data Bridge Market Research analyses a growth rate in the cytomegalovirus retinitis market in the forecast period 2023-2030. The expected CAGR of cytomegalovirus retinitis market is tend to be around 5.6% in the mentioned forecast period. The market was valued at USD 174.22 million in 2022, and it would grow upto USD 269.41 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Cytomegalovirus Retinitis Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Eye Diseases (Glaucoma, Cataract, Ocular Hypertension, Uveitis), Drug Type (Ganciclovir, Valganciclovir, Foscarnet, Cidofovir, Others), Application (Transplantation, Organ transplantation, Congenital CMV infection), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
F. Hoffman-La Roche Ltd. (Switzerland), Gilead Sciences, Inc (U.S.), Auritec Pharmaceuticals Inc (U.S.), Chimerix.(U.S.), Ionis Pharmaceuticals (U.S.), EyePoint Pharmaceuticals, Inc (U.S.), Sanofi (France), CSL (U.S.), Emcure Pharmaceuticals (India), Endo International Inc (Ireland), Amneal Pharmaceuticals LLC. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Cytomegalovirus retinitis is typically characterized as a cytomegalovirus infection which is a herpes-type virus. In this disease, the retina of the human eye get affected because of weak immune system in people which can be due to AIDS, leukaemia and even pregnancy. The typical symptoms associated with cytomegalovirus include flashes and loss of peripheral, blind spots, blurred vision in the eyes. It generally leads to haemorrhagic inflammation of retina, therefore the treatment is very much essential at early stage.
Cytomegalovirus Retinitis Market Dynamics
Drivers
- Increase in Elderly Population
The market is projected to witness a heavy growth rate during the forecast period driven by the factor of an aging population. The growing demand of the market is a replication of the increasing aged population, as people aged over 60 years frequently develop these conditions in which eyes have reduced elasticity and in turn it affects the normal functioning. This boost the market growth.
Opportunities
- Increasing Developments in Treatment and Diagnostic Methods
Intravenous therapy has been widely used to treat and protect the eye against systemic infection. Additionally, higher longevity has been witnessed with Foscarnet compared to Ganciclovir. Systemic treatment is used to treat the HIV virus through a combination of reverse transcriptase and protease inhibitors, that is a highly active anti-retroviral therapy to restore immune system besides raising the T-helper cell counts. In several laboratories, the enzyme-linked immunoassay is the most common serological test for CMV infection. PCR technology is also used for testing saliva and urine samples.
- Increasing Demand for Cidofovir
The increasing demand for cidofovir is somewhat noosting boosting the market's demand. This drug is used along with probenecid to treat a specific viral eye infection (retinitis caused by CMV) in people suffering from AIDS. It reduces the risk of blindness and several other ocular problems.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified healthcare professionals who are unable to treat the patients with suitable treatments could limit the growth of the global cytomegalovirus retinitis market during the forecast period.
- High cost of treatment
The increasing expenditure associated with the treatment of cytomegalovirus retinitis hamper the market growth. It has been witnessed that intraocular therapy is highly effective in controlling infection, and is moderately costly than systemic and superior to intravenous. Intraocular implants need replacement after a gap of 6-8 months, particularly among those with lower levels of T-helper cell counts and thus, it demands a heavy splurge of expenditure.
This cytomegalovirus retinitis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cytomegalovirus retinitis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Cytomegalovirus Retinitis Market
The Covid-19 pandemic greatly affected the market because of the reduction in number of patient visits in hospitals and clinics for cytomegalovirus retinitis and interruption of several alternative procedures and outpatient visits. Although, the market is projected to recover with a continuation of activities across various domains and approval and administration of Covid-19 vaccines.
Global Cytomegalovirus Retinitis Market Scope
The cytomegalovirus retinitis market is segmented on the basis of eye diseases, drug type, application, route of administration, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Eye Diseases
- Glaucoma
- Cataract
- Ocular Hypertension
- Uveitis
Drug Type
- Ganciclovir
- Valganciclovir
- Foscarnet
- Cidofovir
- Others
Application
- Transplantation
- Organ transplantation
- Congenital CMV infection
Route of Administration
- Oral
- Parenteral
- Ocular
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Global Cytomegalovirus Retinitis Market Regional Analysis/Insights
The cytomegalovirus retinitis market is analyzed and market size insights and trends are provided by eye diseases, drug type, application, route of administration, distribution channel and end user as referenced above.
The major countries covered in the cytomegalovirus retinitis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific has been witnessing a positive growth for cytomegalovirus retinitis market throughout the forecasted period due to increased government awareness programs, rising population of affluent patients and number of generic drugs.
North America dominates the market due to the presence of several key manufacturers of the product and, increasing research and development activities and healthcare expenditure.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Cytomegalovirus Retinitis Market Share Analysis
The cytomegalovirus retinitis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cytomegalovirus retinitis market.
Key players operating in the cytomegalovirus retinitis market include:
- F. Hoffman-La Roche Ltd. (Switzerland)
- Gilead Sciences, Inc (U.S.)
- Auritec Pharmaceuticals Inc (U.S.)
- Chimerix. (U.S.)
- Ionis Pharmaceuticals (U.S.)
- EyePoint Pharmaceuticals, Inc (U.S.)
- Sanofi (France)
- CSL (U.S.)
- Emcure Pharmaceuticals (India)
- Endo International Inc (Ireland)
- Amneal Pharmaceuticals LLC. (U.S.)
SKU-